InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Gilead's rejected patent application highlights Section 3(d) uncertainties

Peter Leung, Hong Kong


Nearly two years after the Novartis decision, questions about India's Section 3(d) remain

The patent office's written decision points to some unanswered questions surrounding Section 3(d) of the Patents Act. The provision states that where an applicant seeks to patent a new form of a known substance, the application must show that the...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog


null null null

null null null


November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing



Most read articles

Supplements